Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.
Author Profile
Suitability for Best Researcher Award
Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.
Education:
Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.
Professional Experience:
Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.
Research Interests:
Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.
Recognition and Impact:
Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.
Citations:
Citations – 576
h-index – 14
i10-index – 19
Conclusion:
Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.
Top Notable Publications
Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway
Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …
Journal: Oxidative Medicine and Cellular Longevity
Year: 2020 📅
Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow
Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …
Journal: Journal of Translational Medicine
Year: 2019 📰
C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase
Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu
Journal: Journal of Cellular and Molecular Medicine
Year: 2017 🧬
C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways
Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou
Journal: Oncotarget
Year: 2017 💡
Identification of biomarkers for unstable angina by plasma metabolomic profiling
Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu
Journal: Molecular BioSystems
Year: 2013 🔬
Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction
Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …
Journal: Canadian Journal of Cardiology
Year: 2018 💓
Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention
Author(s): Q Zhao, R Zhang, J Hou, B Yu
Journal: Acta Cardiologica Sinica
Year: 2018 ❤️
C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway
Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …
Journal: Frontiers in Pharmacology
Year: 2021 💪
Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection
Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou
Journal: International Heart Journal
Year: 2016 ❤️
Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study
Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou
Journal: Scientific Reports
Year: 2016 🐇
Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis
Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu
Journal: Biomolecules & Therapeutics
Year: 2018 💉
Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …
Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou
Journal: Experimental and Therapeutic Medicine
Year: 2017 🏥
Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation
Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …
Journal: Clinical Science
Year: 2019 💉
Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study
Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu
Journal: BioMed Research International
Year: 2018 🧪
Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice
Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …
Journal: Journal of Molecular Endocrinology
Year: 2019 🐁